Latest Views & News

Company Becomes a 3-Bagger in 1 Day To Show that Medical Pioneers Can Win Through.

By Malcolm Stacey | Saturday 30 November 2019

Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

Hello, Share Greeters. One probably goes on a bit too much about one’s long-held belief that a monitor investment in a pocket pharmaceutical venture can reap huge rewards very quickly. At the same time, we must acknowledge that a medical share can fall like a lead anvil from a church tower when, for example, a line of research comes to naught.

You must be a registered member to read this story
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £5.99 per month for all articles, the Bearcast, and our seven year archive.

Filed under:

Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Monday »


Just 26 days to go: Book Now!

Sunday »


Me and “The Millionaire Next Door”

Tuesday »


Synectics – a recovery Buy?



Malcolm Stacey is Moving House

Monday »


Wood Group - a Buy (again)?



Video: Bubbles always implode